BioCryst Pharma wins federal contract to continue making Ebola drug
March 31, 2015 at 07:26 AM EDT
March 31 (Reuters) - BioCryst Pharmaceuticals Inc said it won a U.S. government contract for the continued development of its potential treatment for viral diseases, including Ebola.